Clinical Trial

Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes

Study acronym: CLARITY
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placebo) for 8 weeks and answer validated electronic surveys assessing cognitive function delivered to them through a text message (SMS) link or through email.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-07-02; most recent amendment 2026-03-05.
Status change: Completed → Active, Not Recruiting 2026-03-05
Status change: Active, Not Recruiting → Completed 2025-12-09
Status change: Recruiting → Active, Not Recruiting 2025-09-02
Status change: Not Yet Recruiting → Recruiting 2025-07-30
Trial Details
NCT Number NCT07060898
Lead Sponsor Amazentis SA
Collaborators: Radicle Science (sponsor)
Conditions Aging, Cognitive Decline, Brain Fog, Cognitive Function
Enrollment 650 participants
Start Date 2025-07-29
Primary Completion 2025-11-20 (estimated)
Study Completion 2026-11-20 (estimated)
Updated on ClinicalTrials.gov 2026-03-06